Generic names: emtricitabine, rilpivirine, and tenofovir disoproxil fumarate
September 21 2017 4:14 AM EST
September 21 2017 11:36 AM EST
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Generic names: emtricitabine, rilpivirine, and tenofovir disoproxil fumarate
Maker:
Gilead Sciences
Complera.com
What it does:
Helps prevent replication of HIV
Traditional dosage:
One tablet (200 mg of emtricitabine, 25 mg of rilpivirine, and 300 mg of tenofovir disoproxil fumarate), once daily, with a meal. Rilpivirine is an NNRTI, the other components NRTIs. Complera is for those who are new to antiretroviral drugs and have viral loads of 100,000 copies/ml or less.; or as a replacement regimen for individuals with a viral load of 50 copies/ml or less and no resistance to any components.
Drug interactions, precautions, & recommendations:Do not take with medicines that contain lamivudine (Epivir, Epivir-HBV, Epzicom, Combivir, Trizivir), other antiretroviral medications, antiseizure or antituberculosis drugs, proton pump inhibitors (Kapidex, Dexilant), adefovir (Hespera), St John’s Wort, or more than one dose of dexamethasone. Use caution with antacids, antifungal medications, H2-receptor antagonists, antibiotics, or methadone. If taken with Harvoni, you should be monitored.
Side effects:
Most serious: buildup of lactic acid in blood, severe liver problems, kidney damage, hepatitis B flare-up, depression, bone thinning, changes in immune system
Other: insomnia, headache, rashes, diarrhea, nausea, fatigue, dizziness, depression, abnormal dreams, vomiting, stomach or other pain, weight gain